Benzinga | Aug 13, 2020 04:55PM EDT

Cidara Therapeutics Q2 EPS $(0.45) Up From $(0.47) YoY, Sales $3.39M

Cidara Therapeutics (NASDAQ:CDTX) reported quarterly losses of $(0.45) per share. This is a 4.26 percent increase over losses of $(0.47) per share from the same period last year. The company reported $3.39 million in sales this quarter.